Saturday, 20 Sep 2025
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Subscribe
Life Care News
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
    NewsShow More
    Woxsen University Secures Top 5 Position in India in QS Business Masters Rankings 2025-26
    Woxsen University Secures Top 5 Position in India in QS Business Masters Rankings 2025-26
    20/09/2025
    Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation
    Huawei Cloud: Empowering Customers to Succeed in Global Markets Through Continuous Innovation
    20/09/2025
    Grvt Raises M to Pioneer Privacy-First Onchain Finance and Unlock Trillion-Dollar Markets
    Grvt Raises $19M to Pioneer Privacy-First Onchain Finance and Unlock Trillion-Dollar Markets
    19/09/2025
    Global Roadshows Drive Momentum for the 138th Canton Fair
    Global Roadshows Drive Momentum for the 138th Canton Fair
    19/09/2025
    Bigg Boss 19: Nominations Drama Unfolds – Who’s Safe and Who’s at Risk?
    Bigg Boss 19: Nominations Drama Unfolds – Who’s Safe and Who’s at Risk?
    18/09/2025
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
  • 🔥
  • news
  • global
  • june
  • Business
  • july
  • announced
  • today
  •  and
  •  the
  • company
Font ResizerAa
Life Care NewsLife Care News
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Search
  • Home
  • Business
    • Business Wire
    • Globenews Wire
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Health

Fermenta Board Approves Sale of Environmental Solutions Business to Wholly Owned Subsidiary

PRNW Agency
Last updated: 20/09/2025 2:31 PM
PRNW Agency
Share
5 Min Read
Fermenta Board Approves Sale of Environmental Solutions Business to Wholly Owned Subsidiary
SHARE
Fermenta Board Approves Sale of Environmental Solutions Business to Wholly Owned Subsidiary
  • Strategic transfer to enhance operational focus and create dedicated environmental solutions platform
  • To enable specialized management and accelerated growth of environmental business vertical that includes waste management, water treatment, and bioremediation
  • Strengthens Fermenta’s commitment to sustainable development through focused business structuring

THANE, India, Sept. 19, 2025 /PRNewswire/ — Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India’s leading manufacturer of premium-grade APIs, intermediates, and nutritional premixes for the global markets, today announced that its Board of Directors has approved the sale of its environmental solutions business operations to a wholly owned subsidiary, Fermenta Environment Solutions Private Limited (FESPL) on a slump sale basis. This strategic business transfer, effective 1 October 2025, represents another important milestone in Fermenta’s commitment to sustainable innovation and environmental stewardship and enhances operational focus both at parent and subsidiary level.

- Advertisement -

Following this transfer, the subsidiary will continue and expand the business of conceiving, designing, providing, and manufacturing for sale and distribution a wide range of environmental solutions. The subsidiary’s comprehensive portfolio will include—but not be limited to—solid waste management, wastewater and water management, lake and pond bioremediation, fly ash handling, ground and soil remediation, oil sludge treatment, and air pollution management. Additionally, the entity will undertake the installation, operation, and maintenance of sewage treatment plants (STPs), water treatment plants (WTPs), and effluent treatment plants (ETPs), either independently or through strategic collaborations.

- Advertisement -

This strategic move integrates scientific capability with sustainable development, positioning FESPL to address one of the most pressing challenges of our time—environmental resilience. The initiative also aligns with Fermenta’s vision to leverage its expertise and capabilities to create solutions that benefit both business and society.

Comment from Prashant Nagre – Managing Director, Fermenta:

- Advertisement -

“The Board’s approval for this slump sale transaction marks a significant step in our journey toward comprehensive sustainability leadership. By transferring our environmental solutions portfolio to a dedicated subsidiary, we are creating a focused entity that can accelerate growth and innovation in this critical sector. This structured approach will enable specialized management, enhanced operational efficiency, and targeted resource allocation at both parent and subsidiary levels.

- Advertisement -

“The transaction reflects Fermenta’s commitment to applying our decades-honed capabilities to address critical environmental challenges while creating long-term value for all stakeholders. This strategic move perfectly complements our core business and reinforces our strategy of sustainable innovation that benefits both business and society.”

About Fermenta Biotech Limited:

- Advertisement -

Fermenta Biotech Limited (www.fermentabiotech.com) delivers best-in-class, science-validated nutritional ingredients across pharmaceuticals, dietary supplements, food & beverage, veterinary, and animal nutrition industries. Our state-of-the-art manufacturing facilities located at Kullu (Himachal Pradesh), Dahej (Gujarat), and Tirupati (Andhra Pradesh), supported by the R&D Excellence Centre at Thane (near Mumbai) drive Fermenta’s comprehensive portfolio of premium vitamins, nutritional premixes and ingredients that exceed the unique needs and stringent regulatory standards of over 400 discerning customers in more than 60 countries. With decades of expertise at global-scale complex manufacturing, Fermenta also provide research-based custom solutions in green chemistry, APIs & intermediates, and environmental solutions.

- Advertisement -

Safe Harbour Statement

Statements in this document relating to future status, events, or circumstances, including but not limited to statements about plans and objectives, market opportunities, competitive positioning, slump sale transaction potential, the progress and results of research and development, potential project characteristics, project potential, and target dates for project related issues are forward-looking statements based on estimates and the anticipated effects of future events on current and developing circumstances. Such statements are subject to numerous risks and uncertainties and are not necessarily predictive of future results. Actual results may differ materially from those anticipated in the forward-looking statements due to various factors including market conditions, regulatory changes, competitive dynamics, and other business risks. Fermenta Biotech Limited assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions, or other factors, except as and when required by applicable law.

- Advertisement -

Contact:
Mr. Varadvinayak Khambete
varadvinayak.khambete@fermentabiotech.com

- Advertisement -

Logo: https://mma.prnewswire.com/media/2740927/Fermenta_Biotech_Logo.jpg
Logo : https://mma.prnewswire.com/media/2676912/5409901/75_Years_of_Trust_Logo.jpg

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/fermenta-board-approves-sale-of-environmental-solutions-business-to-wholly-owned-subsidiary-302561587.html

- Advertisement -
The Lamborghini Temerario GT3 Born and bred in SantAgata Bolognese
2025/2027 Advanced Olympic Research Grants awarded
SEMI Reports Global Total Semiconductor Equipment Sales Forecast to Reach $125.5 Billion in 2025
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
Axis Bank Launches Sparsh Week 2025: ‘Raising the Bar’ Nationwide
TAGGED:approvesboardBusinessenvironmentalfermentanewsownedsalesolutionssubsidiarywholly
Share This Article
Facebook Copy Link Print
- Advertisement -

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.
FacebookLike
XFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
LinkedInFollow
MediumFollow

Most Selling Products

Top Picks, Trending Now – Discover the Best Sellers!
Tecno Camon 20 Premier 5G

Tecno Camon 20 Premier 5G

Dark Welkin | 8GB RAM + 512GB Storage (Expandable RAM up to 16GB) | Industry’s 1st 50MP RGBW-Pro Camera | Segment-First 108MP Ultra-Wide Macro Lens | 6.67" 120Hz 10-bit AMOLED In-Display

iQOO Z10 Lite 5G

iQOO Z10 Lite 5G

Titanium Blue | 6GB RAM + 128GB Storage | Dimensity 6300 5G with 433K+ AnTuTu Score | Robust 6000mAh Battery | IP64 Rated + Military-Grade Shock Resistance

OnePlus 13s

OnePlus 13s

Black Velvet | 12GB RAM + 256GB Storage | Flagship Snapdragon® 8 Elite Chipset | Exceptional Battery Life in a Compact Form | Lifetime Display Warranty Included

Samsung Galaxy A55 5G

Samsung Galaxy A55 5G

Awesome Iceblue | 8GB RAM + 256GB Storage | Premium Metal Frame | 50MP OIS Main Camera with Nightography | IP67 Water & Dust Resistance | Gorilla Glass Victus+ | sAMOLED Display with Vision Booster

You Might Also Like

Cipla Health takes a humorous spin on real life stories with Astaberry’s campaign ‘Get the Rich Look’
Travel

Cipla Health takes a humorous spin on real life stories with Astaberry’s campaign ‘Get the Rich Look’

16/07/2025
Military Influencer Conference 2025 Announces Return of USAA as Title Sponsor
Business

Military Influencer Conference 2025 Announces Return of USAA as Title Sponsor

12/09/2025
Three global institutions win million dollar prize for the 2025 Antnio Champalimaud Vision Award
Entertainment

Three global institutions win million dollar prize for the 2025 Antnio Champalimaud Vision Award

10/09/2025
Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress
Health

Aicuris Presents Pharmacokinetic Data from the First-in-Human Clinical Trial of AIC468, a Novel Antisense Oligonucleotide Targeting BK Virus, at World Transplant Congress

05/08/2025
Life Care News
Facebook Twitter Youtube Rss Medium

Life Care News:


We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Top Categories
  • Home
  • Business
  • News
  • Tech
  • Health
  • Sports
  • Entertainment
  • Automobile
Usefull Links
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
Copyright © 2015 – 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Life Care NewsLife Care News
Copyright © 2015 - 2025 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?